A 64-year-old man from Quebec has made history as the first individual in North America to undergo a liver transplant using revolutionary technology. This advancement has the potential to significantly increase the availability of livers for transplant procedures.
Gérard Landry, a resident of Nouvelle in Quebec, had been battling liver issues for 15 years, which eventually led to cirrhosis and liver cancer. Prior to his transplant surgery, his doctor shared surprising news that his new liver had been regenerated using a cutting-edge machine introduced at Montreal’s Centre hospitalier de l’Université de Montréal (CHUM).
Referred to as Liver Assist, this innovative technology enables medical professionals to treat and evaluate donated livers outside the body before transplantation. For Landry, this meant receiving a liver that may have been deemed too risky without the regeneration process.
Dr. David Hénault, a specialist at CHUM, spearheaded the project and conducted Landry’s surgery. The Liver Assist system functions by connecting a donated liver to a machine that circulates oxygen-rich fluid through the organ, potentially reversing damage caused by a lack of oxygen during the organ preservation period.
The technology allows doctors to transition to a blood-based solution to assess the liver’s functionality under conditions simulating the human body. Hénault highlighted that this approach can enhance the viability of livers that are susceptible to oxygen-related damage during transplantation.
CHUM typically conducts around 70 liver transplants annually. By utilizing Liver Assist in collaboration with Transplant Québec, the team predicts an increase of 20 to 24 potential livers available for transplantation in the first year, with room for growth as the technology advances.
Studies have indicated that Liver Assist may reduce complications, reoperations, and hospital stays for suitable patients. Landry’s post-transplant progress has been promising, with improved blood work shortly after the surgery, showcasing the potential benefits of the technology in enhancing patient outcomes.
As Landry continues to recover in Montreal, his eventual goal is to return to Gaspésie for further recuperation. Reflecting on his journey, he expressed eagerness to reunite with his loved ones, emphasizing the importance of organ donation discussions. Landry’s story serves as a testament to the transformative impact of advanced medical technologies in improving transplant outcomes and patient experiences.
